We hypothesize that MMP14 functions as both a necessary and sufficient mediator of TGF-β1-driven extracellular matrix remodeling in orbital fibroblasts, thereby constituting a potentially viable therapeutic target for attenuating fibrotic progression in GO. Here, TGFB1 is linked to geroderma osteodysplastica.